Paul Hodgkins

7.9k total citations · 3 hit papers
135 papers, 5.7k citations indexed

About

Paul Hodgkins is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Surgery. According to data from OpenAlex, Paul Hodgkins has authored 135 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Psychiatry and Mental health, 26 papers in Cognitive Neuroscience and 19 papers in Surgery. Recurrent topics in Paul Hodgkins's work include Attention Deficit Hyperactivity Disorder (77 papers), Bipolar Disorder and Treatment (20 papers) and Pharmaceutical studies and practices (15 papers). Paul Hodgkins is often cited by papers focused on Attention Deficit Hyperactivity Disorder (77 papers), Bipolar Disorder and Treatment (20 papers) and Pharmaceutical studies and practices (15 papers). Paul Hodgkins collaborates with scholars based in United States, United Kingdom and Canada. Paul Hodgkins's co-authors include Jennifer Kahle, M. Haim Erder, L. Eugene Arnold, Rahul Sasané, Vanja Sikirica, Monica Shaw, Juliana Setyawan, Susan Young, Hervé Caci and Philip Asherson and has published in prestigious journals such as Gastroenterology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Paul Hodgkins

131 papers receiving 5.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment

2012 528 citations Monica Shaw, Paul Hodgkins et al. profile →
Long-Term Outcomes of ADHD: Academic Achievement and Performance

2015 304 citations Paul Hodgkins et al. Journal of Attention Disorders profile →
Long-term Risk of Acute Diverticulitis Among Patients With Incidental Diverticulosis Found During Colonoscopy

2013 284 citations Paul Hodgkins, M. Haim Erder et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Hodgkins United States	39	3.5k	1.6k	1.1k	664	590	135	5.7k
Douglas E. Faries United States	42	4.4k 1.2×	1.1k 0.7×	1.4k 1.3×	360 0.5×	277 0.5×	154	7.0k
Andrés Martin United States	44	3.0k 0.8×	1.9k 1.2×	2.6k 2.3×	268 0.4×	131 0.2×	179	6.1k
Pierluigi Politi Italy	48	2.1k 0.6×	2.5k 1.5×	1.6k 1.4×	149 0.2×	448 0.8×	197	7.8k
Zheng Chang Sweden	38	2.7k 0.8×	1.4k 0.9×	1.6k 1.4×	294 0.4×	87 0.1×	152	4.6k
Alexandre A. Todorov United States	36	899 0.3×	738 0.5×	888 0.8×	190 0.3×	294 0.5×	102	4.1k
Keith L. Davis United States	53	2.4k 0.7×	891 0.5×	842 0.7×	52 0.1×	472 0.8×	238	9.2k
Ya‐Mei Bai Taiwan	47	3.1k 0.9×	1.5k 1.0×	1.9k 1.7×	81 0.1×	193 0.3×	324	8.2k
Liang‐Jen Wang Taiwan	31	1.5k 0.4×	604 0.4×	676 0.6×	122 0.2×	159 0.3×	229	3.6k
Desirée A. White United States	39	962 0.3×	1.3k 0.8×	195 0.2×	391 0.6×	89 0.2×	97	5.1k
Howard M. Rhoades United States	38	1.3k 0.4×	527 0.3×	1.5k 1.3×	125 0.2×	116 0.2×	104	5.5k

Countries citing papers authored by Paul Hodgkins

Since Specialization

Citations

This map shows the geographic impact of Paul Hodgkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Hodgkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Hodgkins more than expected).

Fields of papers citing papers by Paul Hodgkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Hodgkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Hodgkins. The network helps show where Paul Hodgkins may publish in the future.

Co-authorship network of co-authors of Paul Hodgkins

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Hodgkins. A scholar is included among the top collaborators of Paul Hodgkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Hodgkins. Paul Hodgkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suthoff, Ellison, Mark Kosinski, Paul Hodgkins, et al.. (2022). Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder. Journal of Affective Disorders. 308. 19–26. 19 indexed citations

Mozaffari, Essy, Aastha Chandak, Shuting Liang, et al.. (2021). Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States. Open Forum Infectious Diseases. 9(1). ofab498–ofab498. 3 indexed citations

Mozaffari, Essy, Aastha Chandak, Shuting Liang, et al.. (2021). Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort. Clinical Infectious Diseases. 75(1). e450–e458. 79 indexed citations

Suthoff, Ellison, Brian Werneburg, Paul Hodgkins, et al.. (2021). Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder. Journal of Affective Disorders. 285. 112–119. 16 indexed citations

Gerbasi, Margaret E., Mark Kosinski, Samantha Meltzer‐Brody, et al.. (2021). Achieving clinical response in postpartum depression leads to improvement in health-related quality of life. Current Medical Research and Opinion. 37(7). 1221–1231. 2 indexed citations

Peasgood, Tessa, Anupam Bhardwaj, John Brazier, et al.. (2020). What Is the Health and Well-Being Burden for Parents Living With a Child With ADHD in the United Kingdom?. Journal of Attention Disorders. 25(14). 1962–1976. 22 indexed citations

Hodgkins, Paul, et al.. (2019). Using Matching-Adjusted Indirect Comparisons and Network Meta-analyses to Compare Efficacy of Brexanolone Injection with Selective Serotonin Reuptake Inhibitors for Treating Postpartum Depression. CNS Drugs. 33(10). 1039–1052. 29 indexed citations

Betts, Keith A., Vanja Sikirica, Paul Hodgkins, et al.. (2014). Period Prevalence of Concomitant Psychotropic Medication Usage Among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder During 2009. Journal of Child and Adolescent Psychopharmacology. 24(5). 260–268. 20 indexed citations

Dittmann, Regina, Esther Cardo, Péter Nagy, et al.. (2014). Treatment Response and Remission in a Double-Blind, Randomized, Head-to-Head Study of Lisdexamfetamine Dimesylate and Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder. CNS Drugs. 28(11). 1059–1069. 27 indexed citations

10.

Setyawan, Juliana, Paul Hodgkins, Annie Guérin, et al.. (2013). Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis. Journal of Medical Economics. 16(7). 962–975. 18 indexed citations

11.

Bellows, Brandon K., Joanne LaFleur, T. N. Ginter, et al.. (2013). Automated identification of patients with a diagnosis of binge eating disorder from narrative electronic health records. Journal of the American Medical Informatics Association. 21(e1). e163–e168. 23 indexed citations

12.

Banaschewski, Tobias, César A. Soutullo, Michel Lecendreux, et al.. (2013). The child health and illness profile as a measure of health-related quality of life in stimulant-treated children and adolescents with ADHD.. European Child & Adolescent Psychiatry. 22. 1 indexed citations

13.

Hodgkins, Paul, Juliana Setyawan, Tobias Banaschewski, et al.. (2013). Health utility scores in children and adolescents with attention-deficit/hyperactivity disorder: response to stimulant treatment. European Child & Adolescent Psychiatry. 22. 2 indexed citations

14.

Hodgkins, Paul, Juliana Setyawan, Debanjali Mitra, et al.. (2013). Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patterns. European Journal of Pediatrics. 172(7). 895–906. 71 indexed citations

15.

Sikirica, Vanja, et al.. (2013). Immediate-Release Versus Extended-Release Guanfacine for Treatment of Attention-Deficit/Hyperactivity Disorder. The American Journal of Managed Care. 5. 6 indexed citations

16.

Hodgkins, Paul, et al.. (2012). Persistence, Augmentation, and Consumption of Long-Acting Medications in ADHD Patients. The American Journal of Managed Care. 4. 6 indexed citations

17.

Sikirica, Vanja, M. Haim Erder, Jipan Xie, et al.. (2012). Cost Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Stimulant Compared with Stimulant Monotherapy for the Treatment of Attention-Deficit Hyperactivity Disorder in Children and Adolescents. PharmacoEconomics. 30(8). e1–e15. 23 indexed citations

18.

Erder, M. Haim, James Signorovitch, Juliana Setyawan, et al.. (2012). Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity. Journal of Medical Economics. 15(6). 1078–1087. 7 indexed citations

19.

Hodgkins, Paul, et al.. (2012). Direct Costs of Diverticulitis in a US Managed Care Population. The American Journal of Managed Care. 4(5). 15 indexed citations

20.

Frazier, Thomas, Margaret D. Weiss, Paul Hodgkins, et al.. (2010). Time Course and Predictors of Health-Related Quality of Life Improvement and Medication Satisfaction in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder Treated with the Methylphenidate Transdermal System. Journal of Child and Adolescent Psychopharmacology. 20(5). 355–364. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact